Super-regenerating animals provide clues to medicine
11 January 2022
Pfizer says it will have a new omicron vaccine ready in March
11 January 2022
A double cohort study, which analyzes two groups of cardiovascular patients, observes clear differences between infected and not infected by SARS-CoV-2.
The coordinated study by thirty doctors based in the United States, and published by MedRxIv with the support of Yale University, indicates that el SARS-CoV-2 infection It is associated with a higher risk of cardiovascular problems after infection, in a range of around four weeks. Furthermore, in cases of permanent covid-19, the risk is of suffering from debilitating coronary heart disease.
This analysis aimed to determine the absolute and relative risks of infection in symptomatic and asymptomatic patients; For this, a double cohort work was carried out, consisting of the study of two groups of people with similar characteristics to each other and different realities with respect to the other group. In this case, the cohorts were infected (symptomatic and asymptomatic) and non-infected, all of legal age and subjected to analysis by the Oregon Health & Science University (OHSU), of legal age.
A total of 1.355 patients were studied, with a total of 57% women and 42% people with previous cardiovascular problems, and found evidence of a greater occurrence of myocarditis among those infected. In the six months after infection, it was found 12% of cases in the first group or cohort have cardiovascular disease, and 6% in the second group, which is much larger.. Another interesting conclusion derived from the study is that cardiovascular problems associated with infection were much more numerous among people belonging to ethnic minorities and/or associated with a complex economic situation.
The final intention of the study is to monitor these problems among those infected after recovering from covid-19 and the care, both preventive and palliative, to which they must undergo in the months following the infection, since In addition to myocarditis, significant increases in cases of pericarditis and arrhythmias were also detected in this group. The production of the enzyme ACE2, which protects the heart, lungs and kidneys, decreases with SARS-CoV-2 infection. In the study, cases of Left ventricular hypertrophy and pulmonary vascular thrombosis.
